Fractionated intravesical radioimmunotherapy with213Bi-anti-EGFR-MAb is effective without toxic side-effects in a nude mouse model of advanced human bladder carcinoma-Reference-Cited by-同舟云学术

Fractionated intravesical radioimmunotherapy with213Bi-anti-EGFR-MAb is effective without toxic side-effects in a nude mouse model of advanced human bladder carcinoma

Published:2015-07-15 Issue:10 Volume:16 Page:1526-1534
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Fazel Julia,Rötzer Silvia,Seidl Christof,Feuerecker Benedikt,Autenrieth Michael,Weirich Gregor,Bruchertseifer Frank,Morgenstern Alfred,Senekowitsch-Schmidtke Reingard

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/15384047.2015.1071735

Reference37 articles.

1. The global burden of urinary bladder cancer

2. Cancer Statistics, 2007

3. Bladder cancer, a review of the environmental risk factors

4. Bladder Cancer: A Review of Non-Muscle Invasive Disease

5. Diagnosis, evaluation and treatment of carcinoma in situ of the urinary bladder: The state of the art

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in bismuth utilization for biomedical applications – From a bibliometric perspective;Coordination Chemistry Reviews;2024-10

2. Review of current status of targeted alpha therapy in cancer treatment;Nuclear Medicine Review;2023-02-16

3. Functional and Molecular Imaging Techniques;Radiology of Infectious and Inflammatory Diseases - Volume 1;2023

4. Biodistribution of 213Bi–Metallothionein and 213Bi–IgG in Intact Mice;Physics of Atomic Nuclei;2022-12

5. Bismuth chelation for targeted alpha therapy: Current state of the art;Nuclear Medicine and Biology;2022-11